Post by
CuPenny on Jul 12, 2023 10:25am
Misc Car-T Activity
MIT developing a vaccine boost. Let's go ONCY, stay in front....
https://scitechdaily.com/solid-tumor-eradication-mits-vaccine-delivers-a-boost-to-t-cell-cancer-treatment/
Comment by
westcoast1000 on Jul 12, 2023 12:13pm
If that article refers to ONCY and pela, it would be a big boost to our CAR-T outlook.
Comment by
jimsenior on Jul 12, 2023 7:16pm
@Westcoast. Search - Vaccine delivers a boost to T cell therapy. This study is based on a 2019 study, and certainly does not appear to be pelareorep. Pela seems to be light years ahead of this.
Comment by
westcoast1000 on Jul 13, 2023 12:28am
I agree Jim. My thought was that their work provides more proof of concept for ONCY. We did not just come up with that reasoning alone.
Comment by
jimsenior on Jul 13, 2023 6:37am
@Westcoast. I agree. Perhaps partially explained by the MIT/MAYO Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors; could not find any recent news for them. I am assuming, perhaps wrongly, that the confirmatory CAR T trial will be kept under wraps until other matters are settled. Nothing is guaranteed. Cheers.
Comment by
jimsenior on Jul 12, 2023 12:42pm
@Noteable. Exactly what I was thinking. Would be nice to know for sure; odds are it is pela. Confirmation required. Thanks for keeping the news flow coming.
Comment by
jimsenior on Jul 12, 2023 1:07pm
TO MYSELF. MIT/MAYO PHYSICAL SCIENCES. Looks like pela. What a boost. Pun intended.
Comment by
jimsenior on Jul 12, 2023 1:28pm
@Noteable. In the recent CAR T poster that I cannot find, I think they did not use the boost. So if this cofirmation study used a boost that is very interesting. I have not seen any of this in writing, but if it is pela, WOW.
Comment by
m00nsh0ts on Jul 12, 2023 2:49pm
The technology used in this study has been licensed to a company called Elicio Therapeutics, which is working on developing it for potential testing in patients.
Comment by
jimsenior on Jul 12, 2023 2:59pm
Thanks for clearing that up. The CAR T study for pelareorep that is being confirmed did not use a boost. Where is the news on this confirmatory CAR T study. About due one would think.